After a recent bout of uncertainty and the departure of its longstanding CEO, US cannabis operator MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF) issued its latest quarterly financial report, experiencing heavy losses.

The company posted an adjusted earnings before interest, tax, depreciation and amortization loss of US$35.1 million for its second fiscal quarter of 2020, alongside a net loss attributable to shareholders of US$40.6 million.


Amid the losses, the company’s share price took a hit in Thursday’s (February 27) trading session. The company dropped 11.11 percent as the markets closed, slipping to C$0.36.

“We feel positive about the progress made while remaining aware there is still substantial work to be done,” Ben Rose, executive chairman of the board, said in a statement.

At the end of January, MedMen confirmed the departure of Adam Bierman, its co-founder and CEO. The former leading executive said at the time that he was still a believer in the path ahead for the company.

Following the Q2 quarterly results release, Ryan Lissack, the firm’s newly appointed interim CEO, said MedMen’s next phase “will be defined by financial discipline and strategic growth.”

Across the company’s core assets in California, Nevada, New York, Illinois and Florida, it reported a revenue uptick of 11 percent from the previous quarter for a number of US$44.1 million.

Lissack added that the company’s current timeline includes an assessment of all its operations in order to “narrow the focus on what (it does) best” — which, according to the interim leader, is retail.

MedMen has embarked on a journey to let go of some of its non-core assets, as the firm has accepted that some of its spending was extravagant.

stock chart for medmen

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

A Toronto-based company is set to become the first cannabis operation to transition to the real estate investment trust (REIT) model.

At the start of October, Subversive Real Estate Acquisition REIT LP (NEO:SVX.U,OTC Pink:SBVRF) announced to the market a qualifying transaction that will allow it to finish the process of becoming a special purpose acquisition company (SPAC).

Keep reading... Show less

CEO recognized for economic development across the minority community in the Big Bend Florida region

Trulieve Cannabis Corp. (CSE: TRUL & OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that Chief Executive Officer Kim Rivers was awarded the 2020 Women Business Enterprise of the Year Award. The award celebrates the work of businesses and leaders in Florida’s Big Bend area who are driving innovation, expanding a business, and fostering job creation in the majority-minority community.

Keep reading... Show less

The 64 th storefront in Florida offers the largest inventory of medical cannabis products in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 66th nationwide. The new dispensary will be the first location in Punta Gorda and third in Charlotte County to bring the Company’s wide-ranging catalog of medical cannabis products directly to patients.

Keep reading... Show less
  • Existing At-The-Market (ATM) program now complete
  • New Preliminary Base Shelf Prospectus Has Been Filed
  • Current Cash Position is Approximately $272 million

NYSE | TSX: ACB

Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced it has completed the previously filed At-The-Market (“ATM”) program. Because of this, the Company has filed a new preliminary short form base shelf prospectus (the “Shelf Prospectus”) with securities regulators in each of the provinces of Canada except Quebec and a corresponding shelf registration statement on Form F–10 (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”).

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce that its majority owned subsidiary NeonMind Biosciences (“NeonMind”) has completed an initial production run of all four of its Ayurvedic, functional mushroom coffees.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/66901_b3bb261db486a838_001.jpg

Keep reading... Show less